Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Releasing the Untapped Biotech Potential of the Sea

Published: Friday, November 29, 2013
Last Updated: Friday, November 29, 2013
Bookmark and Share
Exploitation of marine microorganisms has been hampered by the difficulty and expense of isolating their valuable novel chemicals and molecules.

While marine microorganisms have long been identified as an untapped resource of biotechnological potential, the vast majority have until now not been properly cultivated. 

This is a wasted opportunity, and is something that the EU-funded Marine Microorganisms: Cultivation Methods for improving their Biotechnological Applications (MaCuMBA) project aims to rectify. Launched in August 2012, this four-year initiative will improve the isolation rate of marine microorganisms by using innovative new methods. 

These methods include the co-cultivation of interdependent microorganisms that mimic the natural environment. Signalling molecules produced by microorganisms will help to stimulate growth of the same or other species. In fact, these signalling molecules represent an interesting and potentially marketable product in themselves. 

The project consortium took opportunity to take stock of the progress made so far during its first General Assembly, held in Rostock, France in September. "The work carried out by the MaCuMBA project will increase the time and effort invested in getting new microbes in pure culture," says Professor Francisco Rodriguez-Valera, leader of MaCuMBA's Work Package 6 on sequencing, genomic and metagenomic libraries and meta genome analyses. 

"This kind of research is restricted by the high risk that it implies, in spite of the high gain that it provides once significant new microbes are obtained as pure cultures, so projects such as MaCuMBA are important." 

Work Package 6 uses genomics and meta-genomics in order to obtain pure cultures of individual marine microbes and to increase our understanding of their biology. "Sequencing nucleic acids is the fastest and highest yield method presently available for acquiring information about microbes," says Professor Rodriguez-Valera. "We will use these technologies to advance our knowledge of the main microbial characters that play a role in the functions of the ocean ecosystem. Learning how to use these organisms will help us to improve the sustainability of both the ocean ecosystem and the European economy through biotechnological processes." 

In sum, the project will increase the success rate in isolating marine microbes and numerous novel marine bacteria, improve cultivation efficiency of biotechnological relevant marine microorganisms and increase the production rate of new biomolecules with high added value. MaCuMBA also aims to develop culturing methods that mimic natural conditions and advance our understanding of how cell-to-cell communication could affect the isolation and cultivation efficiency of marine microorganisms. 

The MaCuMBA project is being led by the Royal Netherlands Institute for Sea Research (NIOZ), and is a joint venture of 23 partner institutions from 11 EU countries. All partners share the common aim of uncovering the untold diversity of marine microbes using cultivation-dependent strategies. 

The project is scheduled to run until July 2016.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!